Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Mirikizumab (Anti-IL-23) For research use only.
Not for use in humans.

Mirikizumab (Anti-IL-23)

Synonyms: LY­3074828

Mirikizumab (Anti-IL-23) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin 23. Mirikizumab can be used for research on ulcerative colitis. MW: 144.26 KD.

Mirikizumab (Anti-IL-23)

Purity & Quality Control

Batch: A296701 Purity: 99% Protein concentration: 3.33mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Mirikizumab (Anti-IL-23) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin 23. Mirikizumab can be used for research on ulcerative colitis. MW: 144.26 KD.

Product Details

CAS No. 1884201-71-1
Molecular Weight 144.26
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Mirikizumab (Anti-IL-23) | Mirikizumab (Anti-IL-23) supplier | purchase Mirikizumab (Anti-IL-23) | Mirikizumab (Anti-IL-23) cost | Mirikizumab (Anti-IL-23) manufacturer | order Mirikizumab (Anti-IL-23) | Mirikizumab (Anti-IL-23) distributor